TScan Therapeutics
  • About
    • Our Company
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Partners

    About TScan

    TScan is dedicated to changing lives by discovering new cancer targets and developing safe and effective T-cell therapies for patients.

  • Technology
    • Our Approach
    • TargetScan
    • ReceptorScan
    • T-Integrate Cell Engineering
    • Publications

    Technology

    TScan’s therapeutic approach is based on the central premise that we can learn from patients who are winning their fight against cancer in order to treat those who are not.

  • Investors and Media
  • Pipeline
  • Careers
  • About
    • Our Company
    • Management
    • Board of Directors
    • Scientific Advisory Board
    • Partners
  • Technology
    • Our Approach
    • TargetScan
    • ReceptorScan
    • T-Integrate Cell Engineering
    • Publications
  • Investors and Media
  • Pipeline
  • Careers

About

Leadership

  • Management
  • Board of Directors
  • Advisory Board

David Southwell

President and Chief Executive Officer

Gavin MacBeath, Ph.D.

Chief Scientific and Operations Officer

Debora Barton, M.D.

Chief Medical Officer

Brian M. Silver

Chief Financial Officer

Zoran Zdraveski, J.D., Ph.D.

Chief Legal Officer

Shrikanta Chattopadhyay, M.D.

VP of Medical

Leiden Dworak, C.P.A., M.B.A.

Vice President, Finance

Cagan Gurer, Ph.D.

VP of Discovery

Ann Hargraves

VP of Human Resources

Ray Lockard, M.B.A.

Vice President, Technical Operations & Quality

Christopher Malcuit, Ph.D.

Vice President, Process Sciences

Jim Murray

VP of Clinical Operations

Ken Olivier, Ph.D.

VP of Non-clinical Development

Heather Savelle

Vice President, Investor Relations

Interested in joining our team? Explore Careers

©2023 TScan Therapeutics
  • Contact
  • Privacy policy
  • Terms and conditions